Arcellx, Inc. (ACLX)

67.11 -1.51 (-2.20%) USD  |  NASDAQ  |  Jan 23, 12:31
More

Arcellx Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Amicus Therapeutics, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade